Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$122 Mln
Revenue (TTM)
$15 Mln
Net Profit (TTM)
$0 Mln
ROE
-0.2 %
ROCE
-- %
P/E Ratio
--
P/B Ratio
0.4
Industry P/E
--
EV/EBITDA
1.7
Div. Yield
0 %
Debt to Equity
0
Book Value
$--
EPS
$-1.4
Face value
--
Shares outstanding
55,385,100
CFO
$-204.74 Mln
EBITDA
$-317.85 Mln
Net Profit
$-297.13 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Seer Inc (SEER)
| -10.6 | 4.8 | -9.8 | -0.7 | -35.6 | -- | -- |
|
BSE Sensex
| 4.3 | 3.9 | 7.7 | 10.3 | 14.5 | 21.5 | 11.4 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2024
|
2023
|
2022
|
2021
|
|---|---|---|---|---|
|
Seer Inc (SEER)
| 18.9 | -66.6 | -74.6 | -59.4 |
|
S&P Small-Cap 600
| 7.0 | 13.9 | -17.4 | 25.3 |
|
BSE Sensex
| 8.1 | 18.7 | 4.4 | 22.0 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Seer Inc (SEER)
|
2.1 | 121.9 | 15.2 | -85.9 | -648.7 | -26.2 | -- | 0.4 |
| 48.5 | 7,223.3 | 488.7 | 51.4 | 6.9 | 7.3 | 142 | 10.2 | |
| 2.3 | 109.4 | 24,992,845.6 | -7,795,093.4 | -33.8 | -100.1 | -- | 4.0 | |
| 123.6 | 9,115.1 | 845.2 | -86.5 | -13.6 | -7.4 | -- | 7.6 | |
| 1,165.8 | 24,089.3 | 3,830.2 | 849.2 | 28.6 | -- | 28.9 | 3,981.0 | |
| 68.3 | 2,802.8 | 383.8 | -15.0 | -15.1 | -1.9 | -- | 3.3 | |
| 9.1 | 1,676.6 | 2,302.2 | -165.3 | -0.6 | -- | 16.2 | 9.6 | |
| 72.7 | 11,198.7 | 3,952.1 | 412.1 | 9.6 | 6.7 | 28.5 | 1.9 | |
| 123.1 | 10,436.5 | 59,008.9 | 684.5 | 1.9 | 8.4 | 15.5 | 1.3 | |
| 5.2 | 679.3 | 6,176.0 | -1,302.0 | -16.1 | -101.2 | -- | 0.7 |
Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables,... automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California. Address: 3800 Bridge Parkway, Redwood City, CA, United States, 94065 Read more
Founder, CEO, & Chair of the Board of Directors
Dr. Omid C. Farokhzad M.D., Ph.D.
Founder, CEO, & Chair of the Board of Directors
Dr. Omid C. Farokhzad M.D., Ph.D.
Headquarters
Redwood City, CA
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Seer Inc (SEER) stood at $ 360 Mln as on 31-Mar-25
The share price of Seer Inc (SEER) is $2.07 (NASDAQ) as of 21-May-2025 10:42 EDT. Seer Inc (SEER) has given a return of -35.62% in the last 3 years.
Seer Inc (SEER) has a market capitalisation of $ 122 Mln as on 20-May-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Seer Inc (SEER) is 0.39 times as on 20-May-2025, a 89% discount to its peers’ median range of 3.68 times.
Since, TTM earnings of Seer Inc (SEER) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Seer Inc (SEER) and enter the required number of quantities and click on buy to purchase the shares of Seer Inc (SEER).
Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California. Address: 3800 Bridge Parkway, Redwood City, CA, United States, 94065
The CEO & director of Dr. Omid C. Farokhzad M.D., Ph.D.. is Seer Inc (SEER), and CFO & Sr. VP is Dr. Omid C. Farokhzad M.D., Ph.D..
There is no promoter pledging in Seer Inc (SEER).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
282
|
|
|
173
|
|
|
70
|
|
|
11
|
|
|
2,323
|
|
|
1,109
|
|
|
1,045
|
|
|
919
|
|
|
755
|
| Seer Inc (SEER) | Ratios |
|---|---|
|
Return on equity(%)
|
-26.19
|
|
Operating margin(%)
|
-648.71
|
|
Net Margin(%)
|
-566.11
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Seer Inc (SEER) was $0 Mln.
$-0.03
(
